P

Phathom Pharmaceuticals
D

PHAT

5.69000
USD
0.15
(2.62%)
مغلق
حجم التداول
17,577
الربح لكل سهم
-4
العائد الربحي
-
P/E
-1
حجم السوق
389,067,287
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Phathom Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.